Skip to main content

SenesTech, Inc.

corporate_fare Company Profile

SenesTech, Inc.

SNES·NASDAQ·Industrial Applications And Services·CIK 0001680378

The company develops and commercializes products for managing animal pest populations using fertility control and population management strategies. Its current products, ContraPest, Evolve Rat, and Evolve Mouse, focus on rat and mouse populations. Rodents are significant economic pests, threatening human and animal health, food security, and infrastructure globally. They are reservoir hosts for at least 60 zoonotic diseases, posing risks to public health, safety, and agriculture by affecting crops, livestock, stored grain, and farm workers. Diseases like leptospirosis and salmonellosis directly impact livestock reproductive efficiency, contaminate feed, and increase liability for agricultural operators. Rats destroy at least 20% of the global stored food supply annually through consumption and contamination. In the United States alone, rats cause over $27 billion in annual damage to public and private infrastructure by burrowing and gnawing on electrical wiring, insulation, fire-proofing systems, and equipment. Rodents reproduce rapidly, and even intensive lethal control efforts are often undermined by quick population rebound due to high fecundity, early sexual maturity, and density-dependent compensation. Urbanization, climate variability, and aging infrastructure contribute to accelerated rodent population growth and increased infestation pressures globally, including in major metropolitan areas, leading to higher economic costs and public health risks. While lethal methods like traps and rodenticides have been dominant, increasing evidence of non-target secondary poisoning and bioaccumulation has raised environmental and regulatory concerns, driving demand for ecologically-friendly alternatives.

SenesTech, Inc. (NASDAQ:SNES) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for SNES at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • SenesTech CEO to Retire by June 2026; Interim Executive Chair Appointed

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$2.22M
Net Income
-$6.38M
Diluted EPS
-$1.95
Op. Cash Flow
-$5.75M
Free Cash Flow
-$5.89M
Gross Profit
$1.39M
Operating Income
-$6.5M
Cash & Equivalents
$7.58M
Debt / Equity
0.00×
Net Margin
-287.4%
Shares Outstanding
5.22M sh
Source: 10-K · filed 2026-03-12 · accession 0001628280-26-017384
$0.8155
52-week range · as of 2026-08-05 $0.8155 – $5.65
Market cap
$4.42M
Volume
37.3K (0.8× avg)
3-mo avg 49.6K
Live data · 2026-09-20 13:37 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SNES - Filings & News (Page 2)

SNES
Jan 28, 2026, 4:01 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.90
Real-time Price: $0.8155 info
Change: -$1.08 (-57%) info
Market Cap: $4.423M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets